Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies

NCT06643221 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT06643221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06643221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Recruiting
Start date
January 24, 2018
Completion date
May 31, 2031
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

car t-cell therapy, cell therapy, donor lymphocyte infusion, hematopoetic stem cell transplantation, leukemia, lymphoma